The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.174%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Aquis Exchange and ShareSoc Retail Investor Survey

24 Mar 2021 07:00

RNS Number : 2504T
Aquis Exchange PLC
24 March 2021
 

24 March 2021

 

Aquis Stock Exchange/ShareSoc research finds individual investors feel there are barriers to their ability to buy growth stocks

A survey undertaken by Aquis Stock Exchange (AQSE) and ShareSoc has shown that individual investors do not feel they have good, equal access to growth stocks.

Key findings of the survey1

· 55% of individual investors polled feel they don't have, or aren't sure they have, good access to growth companies

· Around 50% of respondents commented that they do not believe that they have enough access to IPOs and fundraises

· Individual investors are frustrated about the privileged access afforded to institutional investors, often at discounted prices

· Over 80% of respondents feel individual investors should be able to trade shares in any public company they choose, irrespective of the exchange it is on

 

Opportunities for the individual investor on AQSE

The survey showed that most individual investors are not taking up the trading opportunities available on AQSE. AQSE is a home to growth companies and is dedicated to providing better access to SME stocks for individual investors.

On the Apex segment of AQSE growth market:

- Individual investors are able to immediately participate in IPOs as a growth prospectus is required

- Short selling is prohibited (aside from Market Makers)

- Spreads are all within 5% - the result of its previously announced innovative Market Maker scheme.

AQSE is regulated by the FCA. Companies listed on AQSE are supported by established corporate advisers, with Canaccord, Liberum, Peel Hunt, Shore Capital, Stifel and Winterflood Securities all publicly supporting AQSE's Market Maker scheme.

AQSE is home to established high-profile names such as Shepherd Neame, Chapel Down, and Arbuthnot Banking, as well as companies at all stages of their growth journey including Samarkand Group and KR1. The average market cap of an Apex stock is approximately £78m.

Brokers that currently offer direct electronic trading in AQSE include Barclays Smart Invest, Jarvis and The Share Centre. Talks are taking place to extend coverage with AJ Bell, Hargreaves Lansdown, Interactive Investor and IG Capital.

ShareSoc support for equal access

ShareSoc believes that regulatory and access issues for individual investors also have consequences for the issuing companies and for the UK economy as a whole. These include:

• Liquidity, spreads, costs and ratings on UK exchanges compare unfavourably with their US equivalents, which discourages many companies from seeking listings in the UK market

• Lack of individual investor access to IPOs and fundraises starves companies of essential growth capital at reasonable cost

These problems could be significantly ameliorated by making it easier and simpler for individual investors to access IPOs and fundraises and to trade shares in all public companies and on all exchanges.

Alasdair Haynes, CEO of Aquis Exchange, said:

"At AQSE, we aim to provide greater and better access to individual investors. Unfortunately, many investors are yet to benefit from AQSE's offering and our provisions for individual investors, including the access to companies from the IPO stage on the Apex segment of our growth market.

By providing more information about the benefits of AQSE I hope that more individual investors will choose to make the most of what it has to offer as we see more brokers giving them equal access through direct electronic trading."

Mike Dennis, Director of ShareSoc, added:

"Many UK investors are frustrated by the restricted access they have to small cap growth companies; they find it difficult to obtain reliable, quality information to assist their decisions and are often excluded from IPOs and fundraises. It is pleasing, therefore, to hear that mainstream brokers are working towards making it possible for individual investors to access shares in many small cap growth companies. This will benefit individual investors, issuing companies, and the UK economy."

 

1The survey was completed by over 450 of ShareSoc's 7,000 members, in January 2021. Half of the respondents have a significant proportion (>20%) of their portfolios in small caps and two thirds of those with significant small cap portfolios define themselves as experienced investors

 

For more information please contact:

 

Aquis Stock Exchange 

Belinda Keheyan, Head of Marketing +44 (0)7768 078 110

Alma PR +44 (0)20 3405 0209

Susie Hudson / Kieran Breheny / Faye Calow aquis@almapr.co.uk

ShareSoc

Mike Dennis mike.dennis@sharesoc.org

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUPPWUPGGRW
Date   Source Headline
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.